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Abstract
Heroin dependence is a chronic relapsing brain disorder, characterized by the compulsion to seek and use heroin. Heroin
itself has a strong potential to produce subjective experiences characterized by intense euphoria, relaxation and release
from craving. The neurofunctional foundations of these perceived effects are not well known. In this study, we have used
pharmacological magnetic resonance imaging (phMRI) in 15 heroin-dependent patients from a stable heroin-assisted
treatment program to observe the steady state effects of heroin (60 min after administration). Patients were scanned in a
cross-over and placebo controlled design. They received an injection of their regular dose of heroin or saline (placebo)
before or after the scan. As phMRI method, we used a pulsed arterial spin labeling (ASL) sequence based on a flow-sensitive
alternating inversion recovery (FAIR) spin labeling scheme combined with a single-shot 3D GRASE (gradient-spin echo)
readout on a 3 Tesla scanner. Analysis was performed with Statistical Parametric Mapping (SPM 8), using a general linear
model for whole brain comparison between the heroin and placebo conditions. We found that compared to placebo, heroin
was associated with reduced perfusion in the left anterior cingulate cortex (ACC), the left medial prefrontal cortex (mPFC)
and in the insula (both hemispheres). Analysis of extracted perfusion values indicate strong effect sizes and no gender
related differences. Reduced perfusion in these brain areas may indicate self- and emotional regulation effects of heroin in
maintenance treatment.
Citation: Denier N, Gerber H, Vogel M, Klarho¨fer M, Riecher-Rossler A, et al. (2013) Reduction in Cerebral Perfusion after Heroin Administration: A Resting State
Arterial Spin Labeling Study. PLoS ONE 8(9): e71461. doi:10.1371/journal.pone.0071461
Editor: Veronika Scho¨pf, Medical University of Vienna, Austria
Received January 28, 2013; Accepted July 5, 2013; Published September 10, 2013
Copyright:  2013 Denier et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by the Swiss National Science Foundation (SNSF) (32003B-127544) (MW, SB, GW, AR-R). The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: niklaus.denier@upkbs.ch
Introduction
In heroin-dependent patients, acute and chronic exposure to
heroin is associated with impairments in a range of cognitive
processes, including impulse control dysfunction [1]. On the other
hand, heroin, chemically known as diacetylmorphine (DAM),
reduces the craving and stress response, accompanied by
relaxation and euphoria [2,3]. It is used as a maintenance drug
in heroin-assisted treatment programs in clinical settings in several
countries [4]. When heroin is injected, it very rapidly crosses the
blood brain barrier, due to the lipophilicity of the acetyl groups
[5]. DAM itself has a short half-life of less than ten minutes and is
decarboxylated into 6-monoacetylmorphine (6-MAM), 3-mono-
acetylmorphine (3-MAM) and then into morphine [6]. While the
metabolite 3-MAM has no effect on opioid receptors, both 6-
MAM and morphine bind to the m-opioid receptor and act as
agonists. Pharmacokinetic modeling leads to the conclusion that 6-
MAM is the main active metabolite during the acute effects after
heroin administration [7]. The metabolite 6-MAM is unique to
heroin and could underlie the intense rewarding effects and the
addictive properties [5,8]. Opioid receptors belong to the class of
G-protein coupled receptors (GCPR); they enhance the probabil-
ity of presynaptic GABA release, which is linked to both the
physiological and the psychotropic effects [9], leading to analgesia,
respiratory depression and reduced blood pressure [10,11].
Psychotropic effects include euphoria, relaxation, excitement,
pleasure, and drowsiness [12], with a rush and an euphoric phase
[13]. The rush is described as lasting only seconds and providing a
rapid release of inner tensions and craving. In contrast, the
euphoric phase may last several hours in a steady state and is
characterized by inner happiness, drowsiness and a feeling of
distance from surrounding events [14].
However, the neurofunctional foundations of the effects
mediated by heroin administration are not well understood.
Pharmacological magnetic resonance imaging (phMRI) permits an
in vivo examination of how psychotropic drugs affect neural
network function in the brain [15–25]. In the present study, we
have examined the acute effects of heroin, using an arterial spin
labeling (ASL) magnetic resonance imaging (MRI) technique. ASL
provides non-invasive and absolute quantification of cerebral
blood flow (CBF), using magnetically labeled arterial blood as an
endogenous contrast agent. This is an advanced and established
imaging method to track acute drug effects. In contrast to blood-
oxygen-level-dependent (BOLD), ASL perfusion has been shown
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to be highly reproducible over long time scales, due to the absolute
quantification of CBF [26]. We have investigated CBF in a task
free resting state during the euphoria phase (after one hour) and
we expected that heroin administration could be related to altered
perfusion in areas of the brain implicated in the regulation of
emotions.
Materials and Methods
Design
This study is part of a randomized, placebo-controlled clinical
trial that has been registered (http://clinicaltrials.gov; ID
NCT01174927). Each patient was scanned twice, with a short
interval between scans (mean 9 SD 3.8 days). On one day, the
subjects received an injection of heroin or placebo (saline) before
the scan and on the other after the scan. Patients received their
regular morning dose of diacetylmorphine, corresponding to half
of their daily dose. The order of heroin and placebo administra-
tion was randomized and patients were blinded to what they
received. A study nurse administered the substance intravenously
20 minutes before the scanning session started. The ASL perfusion
data were acquired one hour after injection (Mean= 69 min;
SD=11 min), corresponding to the euphoria phase during heroin
condition.
Heroin-induced alterations in physiological parameters were
assessed within the scanner by measuring heart rate, blood
pressure and blood oxygen saturation every 5 minutes. The
psychological effects of the applied substance were assessed by a
45-item Heroin Craving Questionnaire (HCQ) [27] and visual
analogue scales (VAS) for intoxication, sedation, withdrawal, and
strength of drug effects (range 0 to 10).
Study sample
Fifteen (9 male) non-left-handed heroin-dependent patients
(ICD-10 = F11.22) were included in the study. All subjects
participated in a national program of standardized DAM
(‘‘heroin’’)-assisted treatment (JANUS Basel, Switzerland). Par-
ticipants were told to abstain from illicit drug use other than
prescribed heroin for the duration of the study, from alcohol
intake for 72 hours and from tobacco consumption for 2 hours
before scanning. Illicit substances and medications were
controlled by a urine test at each session. The exclusion criteria
were a positive alcohol breathalyzer test, a history of significant
medical problems or a major mental disorder (other than
substance use disorders).
Ethics Statement
All patients gave written informed consent and Basel Ethics
Committee (EKBB, Switzerland, [http://www.ekbb.ch/]) ap-
proved the study. Patients were informed that they received their
regular heroin dose (half of a daily dose) before or after the scan.
Image acquisition
Imaging was performed on a 3 Tesla MRI scanner
(Magnetom Verio, Siemens Healthcare, Germany) at Basel
University Hospital. For high resolution anatomical data, a 3D
T1-weighted scan (MPRAGE) was acquired with 16161 mm3
isotropic resolution, repetition time (TR) of 2000 ms, inversion
time (TI) of 1000 ms and echo time (TE) of 3.4 ms. For
perfusion data, a pulsed ASL sequence [28] based on a flow-
sensitive alternating inversion recovery (FAIR) spin labeling
scheme [29] was applied, combined with modified Q2TIPS (TI
periodic saturation) pulse preparation and a single-shot 3D
GRASE (gradient-spin echo) readout [30]. For quantification of
cerebral blood flow (CBF), a time series with 14 incremental TI
(200 to 2800 ms in 200 ms steps) was acquired. For each TI,
two images were acquired: one after slice-selective inversion
(control image) and one after non-selective inversion (labeled
image). The sequence parameters were: repetition time
3200 ms, echo time 12.7 ms and spatial resolution
4.664.664 mm3 (interpolated to 2.362.364 mm3).
Image processing and analysis
Maps of quantified CBF (perfusion maps) were calculated
from ASL raw data. Difference images of label and control
images at different TI were derived and the time course was
fitted to a model describing different stages of arterial blood
passage, using in-house software, [28]. The resulting MHD files
were converted to the NIFTI format with MedINRIA 1.9.2
(http://med.inria.fr).
Further image processing and analyses were performed using
Statistical Parametric Mapping (SPM8; Wellcome Department of
Cognitive Neurology, London, United Kingdom). At the subject
level, MPRAGE images were segmented to gray matter (GM) and
intracranial tissue (ICT; sum of GM, white matter, and
cerebrospinal fluid). Perfusion maps were reoriented to the
standard direction. Both conditions were first realigned and then
coregistered to segmented GM images, resulting in optimal
MPRAGE coregistration. Then perfusion maps were masked
with binarized ICT (binarization threshold: voxel intensity .0.1)
to remove the extracerebral signal. The resulting perfusion maps
were normalized to standard stereotactic MNI (Montreal Neuro-
logical Institute) space by applying the transformation parameters
of normalized MPRAGE images. Finally normalized perfusion
maps were smoothed using a 6 mm full-width-at half-maximum
(FWHM) Gaussian kernel. All processed images were assessed with
respect to quality and registration. See preprocessing steps in
figure 1.
At the group level, a voxel-wise whole brain comparison
between the heroin and placebo conditions was performed with a
basic general linear model (GLM). A proportional scaling method
in SPM8 was used to normalize each subject’s perfusion maps.
MNI coordinates of significant clusters were converted into
Talairach space and labeled with the Talairach Client 2.4.3
(http://www.talairach.org/client.html).
Statistical analysis
We performed a repeated measures (within-subject) analysis
of variance (ANOVA) for whole brain analysis. Pre-processed
heroin and placebo perfusion maps were used as input data.
The following tests were applied: heroin , placebo (higher
perfusion during heroin) and heroin . placebo (lower perfusion
during heroin). Statistical significance was assessed at the
cluster-forming threshold of p,0.01 (uncorrected). At the
cluster level, only clusters with p,0.05 corrected for family-
wise error (FWE) were considered significant [31]. We used the
eigenvariate function in SPM8 to extract mean perfusion values
within the significant clusters. Cohen’s d was performed to
calculate effect sizes of perfusion reduction. We used paired t-
tests in SPSS Statistics (IBM SPSS Statistics; Armonk, NY: IBM
Corp) to analyze differences in HCQ scores, VAS values and
physiological parameters between the heroin and placebo
conditions. To analyze demographic, clinical and perfusion
differences (extracted values) between men and women, we used
independent-samples t-tests. Pearson’s r correlations were
performed to assess the association of heroin dependence
duration and extracted perfusion values.
Acute Effects of Heroin on Cerebral Perfusion
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Results
Demographic and clinical characteristics
The patients mean age was 41 years, they were heroin
dependent for a mean of 21 years and had participated in the
heroin-assisted treatment for a mean of 8 years. Mean daily heroin
dose was 350 mg. Male and female patients didn’t differ
significantly in age (p = 0.10), duration of heroin dependence
(p = 0.76), duration of heroin maintenance (p = 0.70) and daily
dose of heroin (p= 0.44). Some patients also illicitly used other
drugs, one third of patients had an additive substitution with a
small dose of methadone. All participants were cigarette smokers.
None of patients had abused alcohol. The patients’ characteristics
are described in table 1.
Physiological and psychological effects
In the heroin condition, patients had significantly lower heart
rates and blood oxygen saturation, as shown in figure 2 (p,0.01).
The differences remain significant at 60 minutes (p,0.05). There
were no significant differences in the systolic and diastolic blood
pressures, either in the mean values or at 60 minutes.
All patients correctly guessed the substance they had received
before the scanning procedure. Perceived drug effects, feeling of
intoxication and sedation, and relief from withdrawal were
significantly higher during heroin condition than during the
placebo condition (p,0.01). The desire to use heroin did not differ
significantly between the two conditions. See the psychological
effects of heroin in table 2.
Brain perfusion characteristics
Compared to placebo, heroin administration was associated
with relatively low perfusion in three main clusters (threshold:
p,0.01). The first two clusters are within the area of the left and
right insula (p,0.001 and p=0.026; FWE corrected). The third
cluster is in the area of the medial frontal cortex, with peaks in the
anterior cingulate cortex (ACC) and the medial frontal gyrus
(mPFC) (p,0.001; FEW corrected). No significant hyperperfusion
(relative to placebo) was associated with heroin administration.
Brain perfusion characteristics are shown in table 3 and figure 3.
Extracted mean perfusion values of significant clusters are
shown in table 4. Comparison of heroin and placebo condition
showed the following effect sizes in perfusion reduction: left insula
d= 1.38, ACC/MPFC d=0.93, right insula d= 0.82. Male and
female patients didn’t differ significantly in perfusion within all
three clusters (p.0.05). Correlation analysis between extracted
perfusion values and duration of heroin dependence showed no
significant association (p.0.05).
Figure 1. Overview of preprocessing steps at the subject level (SPM8). BIN: Binarization; CSF: Cerebrospinal fluid; GM: Gray matter; WM:
White matter.
doi:10.1371/journal.pone.0071461.g001
Table 1. Socio-demographic and diagnostic characteristics of
the study sample.
Measurements
Subjects
(n =15)
Age (years), mean (SD) 40.9 (6.6)
Male gender, n (%) 9 (60.0)
Partnership, n (%) 6 (40.0)
Employment, n (%) 7 (46.7)
Age at first heroin use (years), mean (SD) 18.1 (3.0)
Duration of heroin dependence (years), mean (SD) 20.5 (7.7)
Duration of heroin maintenance (years), mean (SD) 7.0 (3.9)
Heroin dose (mg/day), mean (SD) 346.0 (173.4)
Methadone substitution, n (%) 5 (33.3)
Methadone dose (mg/day), mean (SD) 30.0 (10.0)
Cocaine use, n (%) 7 (46.7)
Cannabis use, n (%) 4 (26.7)
Tobacco use, n (%) 15 (100.0)
SD: Standard deviation.
doi:10.1371/journal.pone.0071461.t001
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Figure 2. Physiological parameters after heroin and placebo administration. BP: Blood pressure; **: p,0.01.
doi:10.1371/journal.pone.0071461.g002
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Discussion
To our knowledge, this is the first study to measure selective
heroin effects during the euphoria phase with an advanced phMRI
method. We found that heroin administration in heroin-depen-
dent patients is associated with a significant reduction in perfusion
in the insula of both hemispheres, the anterior cingulate cortex
(ACC) and medial prefrontal cortex (mPFC) with strong effect
sizes. Whereas the insula and ACC play an essential role in
emotional regulation and self-awareness [32,33], the mPFC is
known to be important in self-referential processing [34]. The
extended limbic system and the mPFC are frequently involved in
opiate abuse [35,36].
A previous study examined the acute effects of heroin using
functional neuroimaging [13]. Immediately after injection of
heroin, there was increased perfusion in the left anterior cingulate
gyrus, posterior cerebellar lobe, and right precuneus. After
15 minutes, heroin was associated with increased perfusion in
the left superior frontal gyrus [13]. Another study was based on
region of interest (ROI) analyses [37]. Eighty seconds after heroin
injection, perfusion of the amygdalae was enhanced. In our study,
we measured perfusion 60 minutes after heroin injection in a
stable heroin maintenance treatment. In contrast to previous
studies, we did not examine the acute effects in the first minutes
after administration, but steady state effects before or after a
heroin maintenance dose. Moreover, rather than 99mTc-
HMPAO SPECT [13] or perfusion-weighted MR imaging
(PWI) [37], our phMRI study employed ASL CBF quantification,
which is highly reproducible and a well-established method to
measure drug effects [26,38,39].
Interestingly, previous studies with the short acting opioid
remifentanyl, which is used in anesthesia, showed that its acute
Table 2. Psychological effects of heroin.
Measurements Placebo Heroin p-value
HCQ: Desire to use heroin, mean (SD) 3.6 (0 to 14.5) 3.9 (0 to 15) .849
HCQ: Intensions and plans to use heroin, mean (SD) 2.2 (0 to 9) 3.1 (0 to 9.5) .005*
HCQ: Anticipation of positive outcome, mean (SD) 1.4 (0 to 6) 3.0 (0 to 14) .056
HCQ: Relief from withdrawal/dysphoria, mean (SD) 1.0 (0 to 4) 3.1 (0 to 9) .047*
HCQ: Lack of control over use, mean (SD) 3.3 (0 to 15) 2.0 (0 to 11.5) .128
VAS: Intoxication, mean (SD) 1.1 (1.7) 3.7 (2.1) .005*
VAS: Sedation, mean (SD) 1.7 (2.3) 3.3 (2.8) .009*
VAS: Withdrawal, mean (SD) 3.7 (3.0) 0.4 (1.3) .001*
VAS: Drug effect, mean (SD) 0.3 (1.0) 6.5 (2.9) ,.001*
HCQ: Heroin Craving Questionnaire; SaO2: Blood oxygen saturation; SD: Standard deviation; VAS: Visual Analogue Scale;
*: p,0.05.
doi:10.1371/journal.pone.0071461.t002
Table 3. Effects of heroin on brain perfusion in contrast to placebo.
Area Hemisphere
Talairach
coordinates of Cluster size Cluster p-value Cluster p-value
cluster maximum
(x y z) (voxels) (uncorrected) (FWE corrected)
Contrast: P(heroin) , P(placebo)
Insula (BA 13) L 238 3 29 4590 ,.001*** ,0.001***
Superior Temporal Gyrus (BA 38) L 253 15 211
Insula (BA 13) L 230 17 28
Anterior Cingulate (BA 24) R 8 33 8 2664 ,.001*** ,0.001***
Medial Frontal Gyrus (BA 11) L 22 50 211
Anterior Cingulate (BA 24) R 8 23 23
Precentral Gyrus (BA 44) R 63 10 11 1379 0.001*** 0.026*
Insula (BA 13) R 36 13 24
Insula (BA 13) R 40 4 24
Contrast: P(heroin) . P(placebo)
None
BA: Brodmann area; L: left; P: perfusion; R: right; WM: white matter;
*: p#0.05;
***: p#0.001.
Each coordinate triple is a peak area of contrast intensity in one of the two significant clusters and refers to a specific area defined in the atlas of Talairach & Tournoux
(1988).
doi:10.1371/journal.pone.0071461.t003
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effects leads to regional hyperpferusion in the ACC [15,40] and in
the insula [41]. These immediate effects of remifentanyl are in line
with the perfusion findings during the rush phase of heroin [13].
Our findings, which represent more steady state effects of heroin-
assisted treatment, support previous neuroimaging studies. After
intramuscular morphine injection, glucose utilization was de-
creased by 10% in the whole brain, as well as in telencephalic
areas [42]. In opioid-dependent subjects, prefrontal perfusion is
generally reduced and the right-greater-than-left perfusion asym-
metry, normally found in healthy probands, was found to be
reversed [43]. Thus, we can argue that heroin-assisted treatment
with regular and repeated heroin injection may reduce activity in
specific brain areas.
The differences in perfusion, recognized by comparing the
heroin and placebo conditions, may also be caused by hyperperfu-
sion after placebo, which could be associated with withdrawal and
craving. In general, placebo may induce craving and withdrawal
symptoms in heroin-dependent patients [44]. However, all
patients were under stable heroin maintenance treatment and
did not show any acute withdrawal symptoms after the scanning
procedure. We also found relatively low withdrawal levels and
craving scores after placebo administration.
The present heroin-associated modulation of perfusion in
prefrontal and extended limbic regions may also be related to
the abnormal cerebral volumes reported in heroin-dependent
patients [45,46]. A possible direct connection between reduced
Figure 3. Altered regional perfusion in heroin in comparison to placebo condition. A) Relative hypo- (blue) and hyperperfusion (red) in
heroin condition projected on an inflated brain (threshold: p,0.05). Hyperperfusion was not significant. B) Significant hypoperfusion (blue) in heroin
condition (threshold: p,0.01; FEW corrected p,0.05). The z coordinate shows the position of each slice in reference to the Talairach atlas (see
Table 3). The medial prefrontal cortex, the anterior cingulate cortex, and the insular cortex are shown in different colors, in order to clarify the spatial
relationship to the significant clusters.
doi:10.1371/journal.pone.0071461.g003
Table 4. Regional perfusion values of significant clusters.
Region Placebo Heroin Effect size
(Mean/SD/CI 95%) (Mean/SD/CI 95%) (Cohen’s d)
Cluster 1: left Insula 97.07/10.93/91–103 82.10/10.68/73–88 1.38
Cluster 2: right Insula 79.17/11.03/73–85 69.44/12.38/63–76 0.82
Cluster 3: ACC/MPFC 108.71/16.72/99–118 92.16/19.0/82–103 0.93
ACC: Anterior cingulate cortex; CI: Confidence interval; MPFC: Medial prefrontal cortex.
doi:10.1371/journal.pone.0071461.t004
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perfusion during the acute effects of heroin and the reduced GM
volume observed in heroin users could be that recurrent regional
hypoperfusion may lead to metabolic impairment, affecting neural
and glial function, and leading to a reduction in volume. This is in
line with animal models of brain ischemia, which showed that a
decline in CBF is associated with cognitive impairment and neural
death [47,48].
This reduced perfusion in these areas may underlay the feelings
perceived by heroin users, such as relaxation and euphoria [49].
The mPFC and ACC are both parts of the cortical midline
structures and the default mode network (DMN) [34]. The DMN
has been postulated to be an intrinsic brain network, and is active
when self-relevant mental stimulations are processed, such as non-
goal-oriented thinking, autobiographical memory retrieval, envi-
sioning the future, and conceiving the thoughts and perspectives of
others [50], [51,52]. The anatomy of the DMN can be divided
into interacting subsystems, including the medial temporal lobe,
which provides information from prior experiences in the form of
memories and associations [53]. The mPFC acts as integrative
component and provides flexible use of the temporal information
during the construction of self-relevant mental stimulations.
The moderate number of participants limits our findings.
Moreover, our patients were recruited from a population, which
mainly consisted of individuals with long-standing polysubstance
use. Although this problem is virtually inevitable when chronic
heroin-dependent individuals are examined, it may have biased
the results. Another limitation is the lack of a healthy control group
and the use of an inactive placebo that could lead to withdrawal
symptoms.
To conclude, our findings demonstrate that acute adminis-
tration of heroin results in reduced brain activity within the left
anterior cingulate cortex (ACC), the left medial prefrontal
cortex (mPFC) and in the insula (both hemispheres). Reduced
perfusion in these prefrontal and extended limbic areas may
indicate self- and emotional regulation effects of heroin
maintenance treatment.
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